As the patent of Crestor expires, the hyperlipidemia treatment market is expected to be more competitive
As the patent of Crestor expires, the hyperlipidemia treatment market is expected to be more competitive.
It was identified that prescription amount of hyperlipidemia treatment in May is similar to the previous year. Pfizer's 'Lipitor' recorded prescription amount of 8.2 billion won and firmly m...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
